Managing Complications of Cirrhosis
Content Type: presentation
Presenter: Speaker: Mitchell L. Shiffman, MD, FACG Moderator: Mark W. Russo, MD, MPH, FACG
Presenter Disclosure: Mitchell L. Shiffman, MD, FACG Advisory Board: AbbVie, Gilead, HepQunat, Intercept, Mallinckrodt, Shionogi; Research Grant: Aurora, Celgene, Conatus, CymaBay, Enanta, Exalenz, HepQuant, Gilead, Intercept, Mallinckrodt, NGMBio, Viking; Royalties: Slack; Stock options: Exalenz; Speakers Bureau: AbbVie, Daiichi Sankyo, Easai, Gilead, Intercept, Shionogi
Mark W. Russo, MD, MPH, FACG Dr. Russo has no relevant financial relationships.
Event: Virtual Grand Rounds
Release Date: 7/16/2020
Expiration Date: 7/16/2023
Objective: Describe the screening for and management of varices, ascites, hepatorenal syndrome, hepatic encephalopathy, screening for liver cancer.
